Syncona : OMass Therapeutics Announces New Phase of Growth with Move to New Facilities and Team Expansion to Support Portfolio Progress

Move to new purpose-built 16,000ft2 flagship site on ARC Oxford campus to support continued company growth


Expansion of senior leadership team with the appointment of Winfried... | April 19, 2023

Related Keywords

United Kingdom ,Germany ,Bonn ,Nordrhein Westfalen ,Nottingham ,German ,David Williams ,Rosamond Deegan ,Ros Deegan ,Twitter ,University Of Bonn ,Linkedin ,German Centre For Infection Research ,Consilium Strategic Communications ,Oxford Science Enterprises ,Vice President ,Executive Director ,Innate Immunity ,Translational Immunology ,German Centre ,Chief Executive Officer ,Northpond Ventures ,Syncona Limited Stock Exchange ,News ,Information ,Press Release ,Cove ,O ,Few ,Flagship ,Bite ,N ,Parc ,Oxford ,Campus ,Support ,Ontinued ,Company ,Expansion ,F ,Senior ,Leadership ,Team ,Ith ,The ,Appointment ,F Bact Gg00b8p59c08 ,